Navigating the dementia landscape: Biomarkers and emerging therapies

S Maheshwari, A Singh, VA Ansari, T Mahmood… - Ageing Research …, 2024 - Elsevier
The field of dementia research has witnessed significant developments in our understanding
of neurodegenerative disorders, with a particular focus on Alzheimer's disease (AD) and …

Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment

M Kaurav, S Ruhi, HA Al-Goshae, AK Jeppu… - Frontiers in …, 2023 - frontiersin.org
A brain tumor is an uncontrolled cell proliferation, a mass of tissue composed of cells that
grow and divide abnormally and appear to be uncontrollable by the processes that normally …

Advancements in thiol-yne click chemistry: Recent trends and applications in polymer synthesis and functionalization

L George, A Varghese - Materials Today Chemistry, 2024 - Elsevier
Abstract The 2022 Nobel Prize in chemistry brought the world's attention to click chemistry, a
field as fascinating as its name, characterized by attractive features like high yield …

Receptor for advanced glycation end products: dementia and cognitive impairment

A Singh, VA Ansari, T Mahmood, F Ahsan… - Drug …, 2023 - thieme-connect.com
The pathophysiological processes of dementia and cognitive impairment are linked to
advanced glycation end products (AGEs) and their receptor (RAGE). The neurofibrillary …

Ferroptosis signaling pathways: Alzheimer's disease

S Maheshwari - Hormone and Metabolic Research, 2023 - thieme-connect.com
The involvements of iron metabolism, lipid peroxidation, and oxidative stress in Alzheimer's
disease (AD) development have recently received a lot of attention. We also observe that …

Dendrimers in the management of Alzheimer's disease

C Modi, BG Prajapati, S Singh, A Singh… - Alzheimer's Disease and …, 2024 - Elsevier
Alzheimer's disease (AD) is a progressive neurological disorder that affects the brain and
leads to decline in cognitive function, memory, thinking, behavior. Alzheimer's disease is the …

[HTML][HTML] Targeting abnormal tau phosphorylation for Alzheimer's therapeutics

A Singh, VA Ansari, T Mahmood… - Hormone and …, 2024 - thieme-connect.com
Alzheimer's disease (AD) is a widespread neurodegenerative disorder characterized by
progressive memory and cognitive decline, posing a formidable public health challenge …

Breaking barriers in alzheimer's disease: the role of advanced drug delivery systems

D Shekho, R Mishra, R Kamal, R Bhatia, A Awasthi - AAPS PharmSciTech, 2024 - Springer
Abstract Alzheimer's disease (AD), characterized by cognitive impairment, brain plaques,
and tangles, is a global health concern affecting millions. It involves the build-up of amyloid …

A Review on Tau Targeting Biomimetics Nano Formulations: Novel Approach for Targeting Alzheimer's Diseases

A Singh, S Maheshwari, JP Yadav… - … System Agents in …, 2024 - benthamdirect.com
Central nervous system disorders are prevalent, profoundly debilitating, and poorly
managed. Develo** innovative treatments for these conditions, including Alzheimer's …